# Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea

> **NCT00392574** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 282 (actual)

## Conditions studied

- Acute Gastroenteritis in Adult Travelers

## Interventions

- **DRUG:** Prulifloxacin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00392574
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-02
- **Final completion:** 2008-03
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2015-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00392574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00392574, "Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00392574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*